The Biological Foundation of Cord Blood Stem Cells
Cord blood is the blood remaining in the umbilical cord and placenta after a baby is born. In 2026, it is recognized as a premier source of Hematopoietic Stem Cells (HSCs).
Unlike stem cells found in bone marrow, cord blood HSCs are "immature," meaning they have not been exposed to environmental toxins or viruses, making them more adaptable and less likely to be rejected during a transplant.
These cells are unique in their ability to differentiate into various types of blood cells, including red blood cells, white blood cells, and platelets. This "pluripotency" allows them to rebuild a patient's entire immune system following intensive chemotherapy or in the event of a primary immune deficiency. In 2026, the harvesting process is strictly non-invasive, occurring only after the cord has been clamped and cut, posing zero risk to the mother or the newborn.